Innate Pharma S.A. (IPHA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innate Pharma S.A.

    NASDAQ: IPHA · Real-Time Price · USD
    2.02
    0.01 (0.50%)
    At close: Oct 03, 2025, 3:58 PM
    2.03
    0.50%
    After-hours: Oct 03, 2025, 04:00 PM EDT

    Innate Pharma S.A. Cash Flow Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 -46.05M -49.47M -34.05M -7.57M -62.63M -57.97M -15.38M -45.48M -77.37M
    Depreciation & Amortization
    		 1.56M 1.99M 2.59M 5.09M 6.03M 4.42M 4.42M 4.57M 8.76M
    Stock-Based Compensation
    		 3.79M 3.94M 4.56M 3.56M 1.53M 2.12M 2.18M 1.31M 1.25M
    Other Working Capital
    		 32.42M 39.16M -3.91M -13.99M -23.46M -636K 6.55M -12.33M 10.68M
    Other Non-Cash Items
    		 1.71M -2.52M -9.42M 13.85M 53.64M 67.61M 16.68M -919K 71.41M
    Deferred Income Tax
    		 n/a n/a n/a -15.91M -10.17M -22.84M -28.58M n/a n/a
    Change in Working Capital
    		 -2.11M 39.16M 18.26M -31.58M -20.06M -12.5M -8.22M -9.88M -4.25M
    Operating Cash Flow
    		 -41.1M -6.9M -18.06M -32.56M -31.67M -19.15M -26.12M -58.4M -24.94M
    Capital Expenditures
    		 -166K -391K -325K -354K -1.01M -1.12M -1.42M -1.33M -1.77M
    Cash Acquisitions
    		 n/a n/a 300K 300K n/a n/a 5K 7K -25K
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 9.59M 9.59M n/a n/a 3M 3M n/a n/a n/a
    Other Investing Acitivies
    		 5.82M 1K 21.83M 20.68M 1.26M 1.21M 52.5K 36.5K -453K
    Investing Cash Flow
    		 15.24M 9.2M 21.81M 20.63M 2.05M 1.88M -1.37M -1.28M -1.8M
    Debt Repayment
    		 -13.39M -13.36M -4.42M n/a -1.07M -1.07M n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 22.37M 7.35M -907K -2.06M -1.24M -952K 27.24M 27.07M -937K
    Financial Cash Flow
    		 8.79M -6.01M -5.05M -1.97M -2.31M -1.83M 27.43M 27.13M -876K
    Net Cash Flow
    		 50.11M 66.4M 69.18M -13.62M -31.54M -19.53M -1.03M -33.04M -27.56M
    Free Cash Flow
    		 -41.26M -7.29M -18.38M -32.91M -32.68M -20.28M -27.53M -59.73M -26.72M

    Add to Watchlist